Search results
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 5 hours agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Microsoft, Amazon, Pfizer, and others are investing a record $16 billion in France
Quartz· 11 hours agoMicrosoft, Amazon, Pfizer, and other corporations announced Monday that they are investing a record...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Motley Fool via Yahoo Finance· 18 hours agoPfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its...
The Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Zacks via Yahoo Finance· 13 hours agoStocks recently featured in the blog include: Amazon.com, Inc. AMZN, Visa Inc. V, Pfizer Inc. PFE,...
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector -...
Benzinga· 10 hours agoPfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D...
Pfizer's next move: Can it break above $30? | Invezz
Invezz· 15 hours agoPfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. On May 1, 2024, Pfizer...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 2 weeks agoPfizer Inc. (NYSE:PFE) reported its first-quarter financial results for 2024, indicating a solid...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 6 days agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 2 weeks agoPfizer PFE reported first-quarter 2024 adjusted earnings per share of 82 cents, which comfortably...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 2 weeks agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
